" class="no-js "lang="en-US"> PerkinElmer Archives - Medtech Alert
Friday, March 29, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Anona Bamford Ph.D., PerkinElmer Applied Genomics, on Single-Cell RNA Sequencing

In this interview with Anona Bamford from PerkinElmer at the 33rd ECCMID 2023 event, she […]

PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today […]

PerkinElmer Signals Research™ Suite Platform Integrates Scientific Data Silos and Enhances Collaboration for R&D Teams

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the […]

PerkinElmer Launches Next-generation Cell Image Analysis and Management Software to Streamline Drug Discovery Decision-making

PerkinElmer, Inc., a global leading solutions provider in the life sciences, diagnostics, food and environmental […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more